Europe’s premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs

Europe’s Next Act

European innovators helped pave the way for the world’s first COVID-19 vaccines. What’s coming next from Europe’s academic and biotech leaders?

  • What are the weathervane companies that point to where European innovation is headed?
  • What partnering deals are making the European highlight reel?
  • What innovations are investors finding and funding in Europe?
  • Can the U.K.’s split from the EU foster new opportunities for each side?

Join your colleagues for the 21st Bio€quity Europe as industry leaders debate these questions and identify where Europe will continue to provide global leadership in biopharma innovation.

Registration includes:

  • Three days of strategic panels focused on Europe's Next Act
  • 130+ Presentations from European and Asian biotechs handpicked by BioCentury
  • 1x1 virtual partnering using EBD's PartneringOne System
  • European biotech executive report from Insights Partner, McKinsey & Co.
  • Opportunities for digital networking
  • Access to BioCentury business intelligence on European biotech and BioCentury BCIQ database to help you prepare for 1x1 virtual meetings with Presenting Companies and other attendees

Bio€quity Europe 2021 - Faculty

LinkedIn
Karen Bernstein, Ph.D.
Co-Founder & Chairman
BioCentury Inc.
LinkedIn
Kate Bingham
Managing Partner
SV Health Investors
LinkedIn
Simone Fishburn, Ph.D.
VP & Editor in Chief
BioCentury Inc.
LinkedIn
Carole Nuechterlein
Head, Roche Venture Fund
Roche
LinkedIn
Antoine Papiernik
Chairman & Managing Partner
Sofinnova Partners
Moreright-arrow
Sponsorship opportunities available for Bio€quity Europe 2022Speak with a BioCentury representative today
BECOME A SPONSOR
Interested in becoming a Presenting Company for the next Bio€quity Europe in Milan?Apply now to be considered for the Bio€quity Europe Class of 2022
APPLY NOW

Testimonials

“Bio€quity brings together top stakeholders in the life sciences European VC space. The event stands out by delivering quality thought leadership. For the biotech VC community, this is Europe’s flagship event.” 


Nanna Lüneborg, Ph.D.
General Partner
Forbion

“Bio€quity Europe is a 'must go' for both VCs and CEOs of life science companies in Europe ... it is THE event where you can feel the pulse of the industry ...”

Antoine Papiernik
Chairman & Managing Partner
Sofinnova Partners

"Bio€quity is the leading event for the biotech industry in Europe. A masterfully organized event, it brings all actors together and creates an atmosphere and platform for true networking and business development. Complement that with a rich insights agenda that materially contributes to the discussion in the industry and the region, and you have an unmissable event." 


Jorge Santos da Silva, Ph.D.
CEO
MoonLake Immunotherapeutics AG

"Bio€quity Europe is a great meeting for strategic discussions about access to capital and talent. It’s also a key networking event for investors and biopharma executives in Europe."​

Paul Peter Tak, M.D., Ph.D.
President and CEO
Candel Therapeutics

Why Attend?

  • Debate strategies for navigating through talent and capital headwinds over two-plus days of strategic panels and workshops.
  • Understand key talent and capital trends via an exclusive report from Insights Partner, McKinsey & Co.
  • Hear from 100+ rising biotechs selected by the BioCentury team.
  • Meet 1x1 with potential investors and partners using EBD's partneringONE® System – two days in-person (May 17-18), plus two days digital (May 23-24).
  • Network with peers from across the innovation ecosystem.
  • Use BioCentury’s BCIQ database to research companies and help prepare for 1x1 meetings.
  • Watch all session/presentation recordings for 30 days after the event.
  • Your choice: Full-Access Pass* or Digital Pass?
    * Due to record demand, Bio€quity Europe in Milan is sold out. We encourage you to register instead for a Digital Access Pass.

Explore Bio€quity Europe